NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 251 filers reported holding NOVAVAX INC in Q3 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2 | 0.0% | 237 | 0.0% | 0.00% | – |
Q2 2023 | $2 | 0.0% | 237 | 0.0% | 0.00% | – |
Q1 2023 | $2 | 0.0% | 237 | +18.5% | 0.00% | – |
Q4 2022 | $2 | -100.0% | 200 | -15.6% | 0.00% | -100.0% |
Q3 2022 | $4,000 | -82.6% | 237 | -24.0% | 0.00% | -80.0% |
Q2 2022 | $23,000 | 0.0% | 312 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $23,000 | -48.9% | 312 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $45,000 | -44.4% | 312 | -20.4% | 0.01% | -46.7% |
Q3 2021 | $81,000 | -2.4% | 392 | 0.0% | 0.02% | 0.0% |
Q2 2021 | $83,000 | +45.6% | 392 | +25.6% | 0.02% | +36.4% |
Q1 2021 | $57,000 | +62.9% | 312 | 0.0% | 0.01% | +57.1% |
Q4 2020 | $35,000 | +45.8% | 312 | +40.5% | 0.01% | +40.0% |
Q3 2020 | $24,000 | -60.7% | 222 | -69.9% | 0.01% | -64.3% |
Q2 2020 | $61,000 | +771.4% | 737 | +52.0% | 0.01% | +600.0% |
Q1 2020 | $7,000 | +250.0% | 485 | 0.0% | 0.00% | +100.0% |
Q4 2019 | $2,000 | 0.0% | 485 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $2,000 | -33.3% | 485 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $3,000 | – | 485 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |